182 related articles for article (PubMed ID: 38572974)
1. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
3. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
Front Immunol; 2022; 13():947272. PubMed ID: 36032116
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.
Li X; Hou P; Ma W; Wang X; Wang H; Yu Z; Chang H; Wang T; Jin S; Wang X; Wang W; Zhao Y; Zhao Y; Xu C; Ma X; Gao Y; He H
Cell Mol Immunol; 2022 Jan; 19(1):67-78. PubMed ID: 34845370
[TBL] [Abstract][Full Text] [Related]
7. RACK1 attenuates RLR antiviral signaling by targeting VISA-TRAF complexes.
Xie T; Chen T; Li C; Wang W; Cao L; Rao H; Yang Q; Shu HB; Xu LG
Biochem Biophys Res Commun; 2019 Jan; 508(3):667-674. PubMed ID: 30527812
[TBL] [Abstract][Full Text] [Related]
8. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
[TBL] [Abstract][Full Text] [Related]
9. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
Kouwaki T; Nishimura T; Wang G; Oshiumi H
Front Immunol; 2021; 12():700926. PubMed ID: 34249006
[TBL] [Abstract][Full Text] [Related]
10. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.
Shi CS; Qi HY; Boularan C; Huang NN; Abu-Asab M; Shelhamer JH; Kehrl JH
J Immunol; 2014 Sep; 193(6):3080-9. PubMed ID: 25135833
[TBL] [Abstract][Full Text] [Related]
11. Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS.
Zhang W; Wang G; Xu ZG; Tu H; Hu F; Dai J; Chang Y; Chen Y; Lu Y; Zeng H; Cai Z; Han F; Xu C; Jin G; Sun L; Pan BS; Lai SW; Hsu CC; Xu J; Chen ZZ; Li HY; Seth P; Hu J; Zhang X; Li H; Lin HK
Cell; 2019 Jun; 178(1):176-189.e15. PubMed ID: 31155231
[TBL] [Abstract][Full Text] [Related]
12. Tetraspanin 6 (TSPAN6) negatively regulates retinoic acid-inducible gene I-like receptor-mediated immune signaling in a ubiquitination-dependent manner.
Wang Y; Tong X; Omoregie ES; Liu W; Meng S; Ye X
J Biol Chem; 2012 Oct; 287(41):34626-34. PubMed ID: 22908223
[TBL] [Abstract][Full Text] [Related]
13. Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.
Zhang LK; Xin QL; Zhu SL; Wan WW; Wang W; Xiao G
J Virol; 2016 Nov; 90(22):10259-10270. PubMed ID: 27605671
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
16. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
[TBL] [Abstract][Full Text] [Related]
17. Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex.
Cao Z; Xia Z; Zhou Y; Yang X; Hao H; Peng N; Liu S; Zhu Y
Sci Rep; 2016 Sep; 6():33557. PubMed ID: 27629939
[TBL] [Abstract][Full Text] [Related]
18. Activation of RIG-I-Mediated Antiviral Signaling Triggers Autophagy Through the MAVS-TRAF6-Beclin-1 Signaling Axis.
Lee NR; Ban J; Lee NJ; Yi CM; Choi JY; Kim H; Lee JK; Seong J; Cho NH; Jung JU; Inn KS
Front Immunol; 2018; 9():2096. PubMed ID: 30258449
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubiquitin ligase in innate immunity.
Park YJ; Oanh NTK; Heo J; Kim SG; Lee HS; Lee H; Lee JH; Kang HC; Lim W; Yoo YS; Cho H
Cell Signal; 2020 Mar; 67():109520. PubMed ID: 31881323
[TBL] [Abstract][Full Text] [Related]
20. Encephalomyocarditis Virus Abrogates the Interferon Beta Signaling Pathway via Its Structural Protein VP2.
Han Y; Xie J; Xu S; Bi Y; Li X; Zhang H; Idris A; Bai J; Feng R
J Virol; 2021 Feb; 95(6):. PubMed ID: 33328314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
